Nine Masts Capital’s Avidity Biosciences RNAM Stock Holding History

Nine Masts Capital’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-78,786	Closed	-$5.68M	–	300
2025 Q4	$5.68M	Buy	+78,786	New	+$5.09M	0.98%	18

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Nine Masts Capital's RNAM Position: Q1 2026 in Review

Nine Masts Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 78,786 shares — an estimated $5.68M sold.

Nine Masts Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $5.68M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Nine Masts Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Nine Masts Capital sold 78,786 Avidity Biosciences shares in Q1 2026, an estimated $5.68M.
Nine Masts Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Nine Masts Capital's Avidity Biosciences position peaked at $5.68M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Nine Masts Capital's 13F filing for Q1 2026, filed 13 May 2026.